Verano Holdings (VRNO) Non-Current Deferred Tax Liability (2021 - 2026)

Verano Holdings (VRNO) reported Non-Current Deferred Tax Liability of $36.7 million for Q1 2026, down 49.73% year-over-year from $73.0 million in Q1 2025, and little changed quarter-over-quarter from $36.6 million in Q4 2025.

Verano Holdings (VRNO) Non-Current Deferred Tax Liability (2021 - 2026) Analysis & Trends

Verano Holdings (VRNO) has 6 years of Non-Current Deferred Tax Liability data on file, last reported at $36.7 million in Q1 2026.

  • Non-Current Deferred Tax Liability for Q1 2026 came in at $36.7 million, down 49.73% year-over-year; the trailing twelve-month figure through Mar 2026 was $36.7 million (down 49.73% YoY), and the FY2025 annual result was $36.6 million, down 63.85% from the prior year.
  • Non-Current Deferred Tax Liability steadied at $36.7 million in Q1 2026 per VRNO's latest filing, from $36.6 million in the prior quarter.
  • Over five years, Non-Current Deferred Tax Liability peaked at $259.3 million in Q2 2022 and troughed at $2.7 million in Q1 2022.
  • A 5-year average of $141.4 million and a median of $174.8 million in 2024 frame the typical range for Non-Current Deferred Tax Liability.
  • The sharpest annual moves came in 2022 and 2025: Non-Current Deferred Tax Liability soared 26219.88% in 2022, then tumbled 63.85% in 2025.
  • A 5-year view of Non-Current Deferred Tax Liability shows it stood at $209.0 million in 2022, then slipped by 3.0% to $202.7 million in 2023, then slumped by 49.99% to $101.4 million in 2024, then plunged by 63.85% to $36.6 million in 2025, then gained by 0.11% to $36.7 million in 2026.
  • Business Quant data shows VRNO's Non-Current Deferred Tax Liability at $36.7 million in Q1 2026, $36.6 million in Q4 2025, and $71.0 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn
10 Verano Holdings - - 98.98 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 36.69 Mn
Mar 31, 2026 36.69 Mn
Dec 31, 2025 36.64 Mn
Dec 31, 2025 36.64 Mn
Sep 30, 2025 71.02 Mn
Sep 30, 2025 71.02 Mn
Jun 30, 2025 72.37 Mn
Jun 30, 2025 72.37 Mn
Mar 31, 2025 72.98 Mn
Mar 31, 2025 72.98 Mn
Dec 31, 2024 101.36 Mn
Dec 31, 2024 101.36 Mn
Sep 30, 2024 168.16 Mn
Sep 30, 2024 168.16 Mn
Jun 30, 2024 174.79 Mn
Jun 30, 2024 174.79 Mn
Mar 31, 2024 180.25 Mn
Mar 31, 2024 180.25 Mn
Dec 31, 2023 202.69 Mn
Dec 31, 2023 202.69 Mn